Results 111 to 120 of about 1,032 (148)

Drugs incorporated into the Brazilian Unified Health System: document analysis of methodological decisions in budget impact analyses between 2012 and 2024. [PDF]

Epidemiol Serv Saude
Curado DDSP, Silva END.
europepmc   +1 more source

[Nursing consultations in primary health care in Brazil: distribution and productivity in the management of chronic noncommunicable diseasesConsultas atendidas por personal de enfermería en la atención primaria de salud en Brasil: distribución y productividad en las consultas relativas a enfermedades crónicas no transmisibles]. [PDF]

Rev Panam Salud Publica
Mendes IAC, de Almeida EWS, Silva ÍR, de Andrade EMLR, Bernardes RM, Almeida RGDS, Siqueira EF, da Silva MCN, de Godoy S.   +8 more
europepmc   +1 more source

Healthcare judicialization: an analysis of indicators and official data on medications. [PDF]

Rev Bras Enferm
Bernardinis N, Gubert VT, Ferreira CM, Barreto JOM.   +3 more
europepmc   +1 more source

Adherence to pharmacological treatment after hematopoietic stem cell transplantation: context analysis. [PDF]

Rev Bras Enferm
Souza LBF, Soares KD, Vitor AF, Ferreira Júnior MA, Santos VEP, Azevedo IC.   +5 more
europepmc   +1 more source

Evaluation of the performance of biological drugs in the treatment of ankylosing spondylitis: cohort study, Minas Gerais, 2018-2023. [PDF]

Epidemiol Serv Saude
Santos BRAD, Oliveira GA, Silva GD, Santos JBRD, Garcia MM, Junior AAG, Acurcio FA, Alvares-Teodoro J.   +7 more
europepmc   +1 more source

Middle-range theory of the risk for ineffective glucose pattern self-management in hemodialysis. [PDF]

Rev Bras Enferm
Ferreira LL, Martins CCG, Nunes LHS, Araújo AFL, Fernandes MIDCD, Lira ALBC.   +5 more
europepmc   +1 more source

[Access to medicines for the treatment of systemic arterial hypertension and type 2 diabetes mellitus in the Brazilian population: data from the 2019 Brazilian National Health Survey]. [PDF]

Cad Saude Publica
Leal AAF, Galvão MHR, Roncalli ÂG.
europepmc   +1 more source

Variability in public procurement prices for Group 1A drugs in the specialized pharmaceutical component: an observational study, 2013-2022. [PDF]

Epidemiol Serv Saude
Rossignoli P, Pontarolo R, Fernandez-Llimos F.   +2 more
europepmc   +1 more source